Correction of a pathogenic gene mutation in human embryos
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Genome editing has potential for the targeted correction of germline mutations. Here we describe the correction of the heterozygous MYBPC3 mutation in human preimplantation embryos with precise CRISPR-Cas9-based targeting accuracy and high homology-directed repair efficiency by activating an endogenous, germline-specific DNA repair response. Induced double-strand breaks (DSBs) at the mutant paternal allele were predominantly repaired using the homologous wild-type maternal gene instead of a synthetic DNA template. By modulating the cell cycle stage at which the DSB was induced, we were able to avoid mosaicism in cleaving embryos and achieve a high yield of homozygous embryos carrying the wild-type MYBPC3 gene without evidence of off-target mutations. The efficiency, accuracy and safety of the approach presented suggest that it has potential to be used for the correction of heritable mutations in human embryos by complementing preimplantation genetic diagnosis. However, much remains to be considered before clinical applications, including the reproducibility of the technique with other heterozygous mutations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Germline editing has been used for years in animals, including mice, rats, monkeys and many others, and experiments show that it can be done in both nonviable or viable human embryos as well 110-113 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [112]
In the citing paper
“Of the studies that have been conducted, the reported efficiencies of repair with templates in human embryos are very low (5,7,8).”
From Frequent loss of heterozygosity in CRISPR-Cas9–edited early human embryos (2021) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Orthwein, A. et al. Mitosis inhibits DNA double-strand break repair to guard against telomere fusions. Science 344, 189–193 (2014)”
Cited work 10.1126/science.1248024 · retracted 2025-01-09 · notice 10.1126/science.adv1263 · this paper published 2017-08
Citations
Cites
1 retracted
Mitosis Inhibits DNA Double-Strand Break Repair to Guard Against Telomere Fusions
Orthwein, A., Fradet-Turcotte, A., Noordermeer, S. M., Canny, M. D., Brun, C. M., Strecker, J., Escribano-Diaz, C., & Durocher, D. (2014) · Science · doi:10.1126/science.1248024 · Cited by 319
RetractedA Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Self-citationAntoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Cited by
Items 901–948 of 948
Principles of novel cellular and molecular cardiovascular therapeutics
Furtado, M., Ribeiro, M., Martins, S., Carvalho, T., & Carmo‐Fonseca, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-822951-4.00042-4
Transhumanisme : de nouveaux droits ?
Mahalatchimy, A., & Nicolas, G. (2024) · DICE Éditions eBooks · doi:10.4000/11zci
CRISPR-Cas9 Gene Editing Therapy, a Curative Hope for Sickle Cell in Nigeria, West Africa
Olowu, B. I., Olaide, A., & Tinubu, O. B. (2024) · International Journal of Genetics and Genomics · doi:10.11648/j.ijgg.20241203.11
Human genetics: Establishment of cause-and-effect relationships
Saido, T. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28979-8.00013-9
de Oliveira, P. L. S. P., Viduedo, P. H. Z., Martins, V. B. L., Destêfani, A. C., & Destefani, V. C. (2024) · Revista Ibero-Americana de Humanidades, Ciências e Educação · doi:10.51891/rease.v10i8.15340
Development and Exploration of End-User Healthcare Technology Acceptance Models
Wei, X. (2021) · University of North Texas Digital Library (University of North Texas) · doi:10.12794/metadc1808396
Application and Prospect of Gene Editing Technology in Immunotherapy
Zhao, Y. (2025) · Highlights in Science Engineering and Technology · doi:10.54097/814b9h72
“In 2017, researchers from Oregon Health Sciences University in the United States pointed out that CRISPR/Cas9 technology can help repair the mutated gene MYBPC3 related to early embryonic hypertrophy in the human body, and explored the safety of CRISPR technology [46].”
Research Guideline Recommendations for Research on Stem Cells, Human Embryos, and Gene Editing
Var, S. R., Strell, P., Shetty, A. V., Roman, A., Clark, I. H., Crane, A. T., Dunbar, G. L., Fink, K. D., Grande, A. W., Parr, A. M., et al. (2025) · Cell Transplantation · doi:10.1177/09636897241312793 · Cited by 2
“However, subsequent studies minimized mosaicism by modulating the cell cycle stage during editing 65 .”
CRISPR/Cas9-Based Genome Editing in Precision Medicine: Current Trends and Recent Advancements
Ullah, I. (2024) · Premier Journal of Genetics · doi:10.70389/pjg.100001 · Cited by 3
Enhancing CRISPR-Cas9 On-Target Activity Prediction Employing Catboost Machine Learning Models
Hoang, K. T., Hoang, C. K., & Hoang, D. T. (2024) · International Conference on Knowledge and Systems Engineering/Proceedings · doi:10.1109/kse63888.2024.11063519 · Cited by 2
“Genome editing, which involves the deletion, insertion, replacement, and alteration of DNA at specific sites within a living organism’s genome, has emerged as a powerful tool for genetic engineering [5], [13], [14].”
Koufi, E. A., Alqosaibi, A. I., Alameddin, A. M., Nabil, N., Taha, P. S., Yasser, M., Abbas, S., Abdel-Ghany, S. E., Algosaibi, S., & Elsheikh, E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29890-5.00002-6 · Cited by 1
Role of CD8+ cytotoxic T cells in recurrent pregnancy loss
Malik, J. A., & Agrewala, J. N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13657-3.00016-7
The Targets Problem for Germline Genetic Interventions
Cwik, B. (2025) · The International Library of Bioethics · doi:10.1007/978-3-031-94690-5_8 · Cited by 1
Advancement of CRISPR/Cas9 in Translational Biomedicines
Atale, N., Kong, Q., & Rani, V. (2025) · Advances in Science, Technology & Innovation/Advances in science, technology & innovation · doi:10.1007/978-3-031-80973-6_5 · Cited by 1
Human genome editing: We should all have a say
Baylis, F. E. (2017) · doi:10.64628/aam.5kry3gx33
Scientists edit human embryos to safely remove disease for the first time – here’s how they did it
Harper, J. C., & O’Neill, H. C. (2017) · doi:10.64628/ab.gsnwpde4f
How a scientist says he made a gene-edited baby – and what health worries may ensue
Seidel, G. E. (2018) · The Conversation · doi:10.64628/aai.3eyp9jgc3
Developing therapeutics for rare cardiovascular diseases
Lerman, J. B., Koeberl, D. D., Epstein, S., Roessig, L., Stan, R., Halley, M. C., OWENS, A. T., Greenberg, B., Alexander, K. M., Day, S. M., et al. (2025) · American Heart Journal · doi:10.1016/j.ahj.2025.09.004
Gene Editing Nuclear and Mitochondrial DNA
RTreff, N., Eguizábal, C., Montserrat, N., & Belmonte, J. C. I. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21477-6.00389-8
Self-citationChatfield, K. C., Lee, T. M., & Nees, S. N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13279-7.00042-0
Gene editing for inherited cardiac conditions: A new frontier in cardiology
Abdul-Rahman, T., Roy, P., Garg, N. K., Nazir, A., Mehta, K. S., Doshi, N. A., Hassnain, S., Reddi, R., Kanagala, S. G., Ashinze, P. T., et al. (2025) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2025.11.002
CRISPR/Cas9: the future of human gene editing
Zulkifli, N. D., Sani, S. B. M., Wong, C. H., Mahadzan, M., Suhimi, M. H. A., Zulkifli, N., & Das, K. T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33947-9.00009-8
Additional file 1 of Researching the future: scenarios to explore the future of human genome editing
Selin, C. L., Lambert, L. M., Morain, S. R., Nelson, J. P., Barlevy, D., Farooque, M., Manley, H., & Scott, C. T. (2023) · Figshare · doi:10.6084/m9.figshare.24180822
Farris, M., Texter, P. A., Mora, A. A., Wiles, M. V., Mac Garrigle, E. F., Klaus, S. A., & Rosfjord, K. M. (2020) · Figshare · doi:10.6084/m9.figshare.13324087
Lu, Z., Bukhari, S. T. H., Azeem, M., Tariq, N., & Shabbir, M. A. B. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1737251 · Cited by 3
Juan C. Izpisúa Belmonte: The Scientist Who Studies Cellular Aging in Order to Rejuvenate It
Cuesta, M. A. (2026) · Springer eBooks · doi:10.1007/978-3-032-12221-6_39
Gene Therapy for Heart Failure
Thoonkuzhy, T., & Eisen, H. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-12629-0_16
Development of targeted methylome modifications in mammal cells
Lleida, A. A. (2018) · theses.fr (ABES) · doi:10.70675/6e05a7d8z70caz4650zb774z4d6156ab4205
Clonage et modification du génome de Mycoplasma hominis dans la levure Saccharomyces cerevisiae
Rideau, F. (2018) · theses.fr (ABES) · doi:10.70675/9007a937z82f6z49a0z8276zaeaa4619409b · Cited by 2
Deuring, S. (2019) · theses.fr (ABES) · doi:10.70675/4db03bbezce72z4bebzbe45z50c748068479
Génotoxicité des systèmes CRISPR-Cas9.
Cullot, G. (2019) · theses.fr (ABES) · doi:10.70675/cb1809e4zaafbz4fc1z89e9zeb0e5fd69275
Mianné, J. (2020) · theses.fr (ABES) · doi:10.70675/179210b5z933bz4406zb297z7beef82bc3ae
Etude de la contribution de l'hormone adipocytaire leptine dans la pathogenèse du syndrome de Rett
Belaïdouni, Y. (2022) · theses.fr (ABES) · doi:10.70675/f69d2875zfa9fz4465z917eza8e7b93935c6
Factors that contribute to B cell oncogenesis in people living with HIV
Shmakova, A. (2023) · theses.fr (ABES) · doi:10.70675/1d51b9d6z9a12z41f9z8f98z0c7f955aeb54
Basu, S., Narayan, M., & Narayan, P. (2026) · Cureus · doi:10.7759/cureus.108722
“…modalities carry distinct regulatory burdens; mechanistic stability directly informs modality choice, and regulatory confidence is strengthened when genetic anchoring, cross-cohort concordance, biomarker reproducibility, and model human fidelity can all be affirmatively demonstrated [17,28].”
InfluentialLi, S., Chen, X. W., Cao, Y., Han, M., Guan, F., Ren, X., Mi, H., Yang, T., Li, M., & Zhao, X. (2026) · Human Mutation · doi:10.1155/humu/7351808 · Cited by 1
“Gene therapy can increase the expression of normal alleles in mutant osteoblasts, potentially ameliorating the severe phenotype [19].”
Nguyen, T. H., Nguyen, H. A., Thi, Y.-V. T., Nguyen, H. T., Cao, A., Do, Q. L., Bui, T. T., Duc, T. C., & Cao, H. (2026) · Biotechnology Journal · doi:10.1002/biot.70274 · Cited by 1
“A recent work conducted by Shoukhrat Mitalipov’s research group reported successful repair of the heterozygous MYBPC3 mutation causing myocardial disease in human preimplantation embryos [178].”
Belloch-Molina, C., da Silva, F. V. S., Morrissey, J. P., & Sousa-Gallagher, M. J. (2026) · Biotechnology Advances · doi:10.1016/j.biotechadv.2026.109001
Introduction to rare genetic diseases in fetal development
Bashir, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27660-6.00007-9
Clustered Regularly Interspaced Palindromic Repeats (CRISPR) Applied to Gametes and Embryos
Ishanzadeh, M. C. S., & Wells, D. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5292-3_24
The myth of Sisyphos and the route of cardiovascular medicine
Lüscher, T. F. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag586 · Cited by 1
The CRISPR/Cas technology landscape: From molecular mechanisms to multidisciplinary applications
Liu, Z., Yang, Y., Li, Z., Li, P., Jia, J., Qiao, X., Su, Y., Qin, Y., Wang, H., Dai, Y., et al. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102484
No bird soars in a calm: therapeutic germline gene editing
Tie, C. (2026) · Trends in Genetics · doi:10.1016/j.tig.2026.08.011
Metadata
- Authors
- Ma, H., Marti-Gutierrez, N., Park, S.-W., Wu, J., Lee, Y., Suzuki, K., Koski, A., Ji, D., Hayama, T., Ahmed, R., Darby, H., Van Dyken, C., Li, Y., Kang, E., Park, A.-R., Kim, D., Kim, S.-T., Gong, J., Gu, Y., Xu, X., Battaglia, D., Krieg, S. A., Lee, D. M., Wu, D. H., Wolf, D. P., Heitner, S. B., Belmonte, J. C. I., Amato, P., Kim, J.-S., Kaul, S., & Mitalipov, S.
- Affiliations
- Oregon Health & Science University (US)
- Institute for Basic Science (KR)
- Salk Institute for Biological Studies (US)
- Seoul National University (KR)
- BGI Group (China) (CN)
- Corresponding author
- Amato, Paula
- Kim, Jin-Soo
- Kaul, Sanjiv
- Mitalipov, Shoukhrat
- ORCID
- Venue
- Nature
- Published
- 2017-08
- Volume
- 548
- Issue
- 7668
- Pages
- 413-419
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2740810575
- Cited by
- 992
- References
- 48
- Citations by year
- 2026: 22 · 2025: 50 · 2024: 47 · 2023: 93 · 2022: 75 · 2021: 107 · 2020: 135 · 2019: 155 · 2018: 217 · 2017: 88
- Type
- journal article
- Language
- en
- Update notices
- expression_of_concern (2017-10-02)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Funders
- Oregon Health and Science University
- Leona M. and Harry B. Helmsley Charitable Trust
- Consorzio Interuniversitario Biotecnologie
- Moxie Foundation
- Government of Jiangxi Province
- Institute for Basic Science (IBSR021-D1, R021-D1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- germline editing, CRISPR/Cas9, MYBPC3 mutation, hypertrophic cardiomyopathy, preimplantation embryo, homology-directed repair, mosaicism, DNA double-strand break repair, cell cycle timing, preimplantation genetic diagnosis, off-target mutations
- MeSH terms
- Gene Editing, Myosin Binding Protein C, Adult, Alleles, Blastocyst, Carrier Proteins, Cell Division, Embryo, Mammalian, Genetic Complementation Test, Heterozygote, Homozygote, Humans, Male, Mosaicism, Mutation, Templates, Genetic, Zygote, S Phase, Gene Targeting, DNA Breaks, Double-Stranded, Recombinational DNA Repair, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.